BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Trigen Holdings AG 

Fraunhoferstrasse 9

Martinsried  Bavaria  82152  Germany
Phone: 44-0-20-7004-2630 Fax: 44-0-20-7004-2631


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Trigen Holdings AG Appoints Dr. Ayad Abdul-Ahad as Chief Executive Officer and Dr. Norbert Bender as Chief Medical Officer 7/23/2008 1:17:26 PM    More...
Trigen Holdings AG's Innovative Platelet Adhesion Inhibitor, PR-15, Successfully Completes First-in-Man Phase I Study 5/1/2007 11:16:22 AM    More...
Trigen Holdings AG Opens IND For The Initiation Of A Phase III Programme For Flovagatran (Formerly TGN 255), Its Novel Intravenous Direct Thrombin Inhibitor (DTI) 2/6/2007 10:34:20 AM    More...
Trigen Holdings AG Obtains Exclusive License To GPVI Technology 1/23/2007 10:31:40 AM    More...
Trigen Holdings AG Initiates Clinical Development With A Novel Therapeutic Protein, targeting Thrombosis And The Progression Of Atherosclerosis 12/13/2006 11:32:49 AM    More...
Trigen Holdings AG Strengthens Its Supervisory Board With The Appointment Of Grahame Cook As A Non-Executive Director 9/27/2006 10:41:41 AM    More...
Trigen Holdings AG Presents Phase II Results For Its Intravenous Direct Thrombin Inhibitor, TGN 255, For The Prevention Of Clotting During Hemodialysis 7/17/2006 12:05:35 PM    More...
Trigen Completes €26.5 Million Financing Round 10/19/2005 5:13:20 PM    More...
Eurand (Milan, Italy) And Trigen Ltd. Announce A Development Collaboration For Trigen's Novel Oral Anticoagulant, TGN 167 10/19/2005 5:12:17 PM    More...

//-->